FDA Needs to Share Trade Info, Shift Import Burdens to Industry

Drug GMP Report
A A
ATHENS, Ga. — The FDA needs dramatic new powers from Congress, including the ability to share trade secrets and proprietary information with other regulators, to better police the drug industry’s supply chain, a top FDA official says.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00